07.08.2015 Views

Deep Anterior Lamellar Keratoplasty as an Alternative to Penetrating ...

Deep Anterior Lamellar Keratoplasty as an Alternative to Penetrating ...

Deep Anterior Lamellar Keratoplasty as an Alternative to Penetrating ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Ophthalmology Volume 118, Number 1, J<strong>an</strong>uary 2011c<strong>an</strong> result in loss of corneal endothelial cells, g<strong>as</strong>-inducedpupillary block, or a failure of a DM detachment <strong>to</strong> resolve.Pos<strong>to</strong>perative double <strong>an</strong>terior chamber, presumably alsorelated <strong>to</strong> operative perforations of DM, required a subsequen<strong>to</strong>perative intervention in 2.2% of c<strong>as</strong>es <strong>an</strong>d, when notsuccessful, w<strong>as</strong> the most common cause of delayed PKconversions in 0.4%. There were 5 (0.3%) repeat DALKprocedures. Donor lamellar graft recipient-bed interfacecomplications such <strong>as</strong> interface haze, DM wrinkling, <strong>an</strong>dinterface v<strong>as</strong>cularization were uncommon at 0.7%, 0.5%<strong>an</strong>d 0.5%, respectively. These complications are unique <strong>to</strong>DALK procedures, where<strong>as</strong> the remaining complicationsnoted in Table 3 (available at http://aaojournal.org) wereindividually less th<strong>an</strong> 0.5% <strong>an</strong>d could have occurred withPK or DALK.Of the 11 comparative studies, there w<strong>as</strong> no signific<strong>an</strong>tdifference in the pos<strong>to</strong>perative BSCVA between the DALK<strong>an</strong>d PK groups in 6 studies, 17,18,22,23,25,26 <strong>an</strong>d there w<strong>as</strong>better BSCVA in the DALK group in one study 27 <strong>an</strong>d betterBSCVA in the PK group in 4 studies. 19–21,24 The onestudy 27 reporting better pos<strong>to</strong>perative vision in the DALKgroup had the largest number of eyes in each group (150/150). Overall, there w<strong>as</strong> no signific<strong>an</strong>t difference betweenspherical refractive error or <strong>as</strong>tigmatism between the DALK<strong>an</strong>d PK groups.Twenty-seven of the additional 31 studies listed in Table2 (available at http://aaojournal.org) presented data aboutpos<strong>to</strong>perative visual acuity, refractive correction, <strong>an</strong>d <strong>as</strong>tigmatismof DALK eyes. There w<strong>as</strong> no signific<strong>an</strong>t differencein pos<strong>to</strong>perative visual acuity between DALK or PK eyes <strong>as</strong>a group, although there w<strong>as</strong> a tendency for lower visualacuity in DALK eyes in which DM w<strong>as</strong> not bared <strong>an</strong>dresidual stroma in the bed exceeded 10% of <strong>to</strong>tal stromalthickness.Immune-mediated donor-graft rejection c<strong>an</strong> be cl<strong>as</strong>sified<strong>as</strong> epithelial, stromal, endothelial, or some combination ofthese. Because corneal endothelium is not replaced inDALK, donor endothelial immune-medicated rejection c<strong>an</strong>no<strong>to</strong>ccur <strong>as</strong> it c<strong>an</strong> in PK. Stromal graft rejection c<strong>an</strong> alsooccur during the pos<strong>to</strong>perative period after DALK <strong>an</strong>d PK.There were 18 immune rejections recorded (1.0%) for the1843 DALK eyes reported in Table 2 (available at http://aaojournal.org). One study 28 reported 7 of 29 patients withDALK for kera<strong>to</strong>conus who had graft rejections, 2 of whomhad progressive v<strong>as</strong>cularization of the graft interface withopacification. One recent study, 29 not included in Table 2(available at http://aaojournal.org), of 129 consecutive eyesof 121 patients with DALK for kera<strong>to</strong>conus recorded 14 of129 episodes (10.9%) of subepithelial graft rejection <strong>an</strong>d 4of 129 episodes (3.1%) of stromal graft rejection, all successfullytreated with a 3- <strong>to</strong> 6-week course of <strong>to</strong>picalcorticosteroids. The majority of graft rejection episodes(n13) occurred in the first year after surgery <strong>an</strong>d in patientswith a his<strong>to</strong>ry of vernal kera<strong>to</strong>conjunctivitis (66.3%).Eighteen of the 129 eyes had a his<strong>to</strong>ry of vernal kera<strong>to</strong>conjunctivitisthat w<strong>as</strong> inactive at the time of surgery.Six of the 11 studies in the DALK/PK comparison group(Table 1; available at http://aaojournal.org) evaluated pos<strong>to</strong>perativeECD of the host corneal endothelium for theDALK groups <strong>an</strong>d of the donor graft endothelium for thePK groups. All demonstrated signific<strong>an</strong>tly higher ECD inthe DALK groups: at 12 months pos<strong>to</strong>peratively in 2 studies,17,20 at 24 months in one study, 18 at 3 years in onestudy, 25 <strong>an</strong>d at all intervals up <strong>to</strong> 5 years in the one study. 26The ECD data for the DALK/PK comparative studies highlightsignific<strong>an</strong>t differences between these surgical techniques(Table 1; available at http://aaojournal.org), withconsistently higher ECD in post-DALK eyes compared withpost-PK eyes.DiscussionThe adv<strong>an</strong>tages of DALK over PK surgery are <strong>as</strong> follows:● Immune rejection of the corneal endothelium c<strong>an</strong>no<strong>to</strong>ccur.● The procedure is extraocular <strong>an</strong>d not intraocular.● Topical corticosteroids c<strong>an</strong> usually be discontinuedearlier with DALK.● There is minor loss of ECD.● Compared with PK, DALK may have superior resist<strong>an</strong>ce<strong>to</strong> rupture of the globe after blunt trauma.● Sutures c<strong>an</strong> be removed earlier with DALK.The most obvious adv<strong>an</strong>tage of DALK is that the hostcorneal endothelium is not subject <strong>to</strong> immune rejection inDALK. Larger grafts approaching the limbus c<strong>an</strong> be usedwith DALK if the goal is complete removal of ectatic tissuein kera<strong>to</strong>conus. Normal-risk patients undergoing PK whoare phakic are generally tapered off of <strong>to</strong>pical corticosteroidsin 6 months, although continuing a daily <strong>to</strong>pical corticosteroiddrop for <strong>an</strong> additional 6 months provided additionalprotection against immunologic rejection in a large,prospective r<strong>an</strong>domized interventional trial of 406 eyes. 30However, this adv<strong>an</strong>tage of DALK over PK is not <strong>as</strong> great<strong>as</strong> one might expect, because immune rejection after PK forkera<strong>to</strong>conus is less likely <strong>an</strong>d kera<strong>to</strong>conus is the most commonindication for DALK. The major long-term adv<strong>an</strong>tageof DALK surgery over PK relates <strong>to</strong> long-term preservationof host corneal endothelial cells <strong>as</strong> me<strong>as</strong>ured by specularmicroscopy <strong>an</strong>d reported <strong>as</strong> ECD.Certain patients require PK, such <strong>as</strong> patients with kera<strong>to</strong>conuswho also have coexisting Fuchs’ endothelial dystrophy.Patients with corneal scarring from conditions such<strong>as</strong> herpes simplex virus, varicella zoster virus, microbialcorneal ulcers, or macular corneal dystrophy who have acompromised corneal endothelium should have PK surgery.However, in the presence of a relatively normal host cornealendothelium, not having <strong>to</strong> use long-term <strong>to</strong>pical, periocular,or systemic immunosuppressive agents <strong>to</strong> m<strong>an</strong>age thegraft is a definite adv<strong>an</strong>tage for DALK, especially if thepatient is a corticosteroid responder or is phakic.<strong>Deep</strong> <strong>an</strong>terior lamellar kera<strong>to</strong>pl<strong>as</strong>ty avoids the intraocular,open-sky segment of the PK procedure. Complications,including positive pressure, iris prolapse, <strong>an</strong>d choroidaleffusion/hemorrhage, are completely avoided with DALK.Tr<strong>an</strong>smission of bacterial infection from donor <strong>to</strong> recipientshould theoretically remain limited <strong>to</strong> keratitis rather th<strong>an</strong>endophthalmitis.212

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!